Danish Study on Embryo Genetic Testing for Single-Gene Disorders
Part of Genetic & congenital clinical trials.
This study looks at how well a genetic test on embryos (called PGT-M) can find specific single-gene disorders. It will help doctors learn more about these tests and improve care for families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be planning to have a genetic test on embryos before they are placed in the womb, specifically to check for a single-gene condition (like cystic fibrosis or Huntington's disease).
- There are no other medical requirements to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This trial is testing a new, more efficient way to perform genetic testing on embryos (PGT-M) for couples who do not have a DNA sample from an affected child. It aims to help families where standard methods are difficult, such as when the carrier has no symptoms, or when the female partner has low egg reserve.
This study tests whether adding a non-invasive genetic test (called NiPGT-A) on the fluid around the embryo can improve success rates for women under 35 who have good-quality embryos. It focuses on the first or second IVF cycle with a single frozen embryo transfer.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
Hear when a new Aneuploidy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.